Viatris Inc
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$20.28−0.17 (-0.83%)
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris Products in Active Development — JANZ by Year
Viatris Products in Active Development — JANZ: 40 in FY2025, down 20.0% from a year earlier.
Latest, FY2025
40
Period ended Dec 31, 2025
Change on a year earlier
-20.0%
50 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below
Where the FY2025 figure comes from
“JANZ 70 50 ~40”
Source: Viatris 2025 Sustainability Report ↗
Reported in Viatris Sustainability Reports.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Products in Active Development — JANZ | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40 | -20.0% | Viatris 2025 Sustainability Report ↗ |
| FY2024 | Dec 31, 2024 | 50 | -28.6% | Viatris 2025 Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 70 | 0.0% | Viatris 2025 Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 70 | +7.7% | Viatris 2024 Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 65 | +44.4% | Viatris 2023 Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 45 | – | Viatris 2023 Sustainability Report ↗ |
Cite this data
StockData. (2026). Viatris Products in Active Development — JANZ, annual FY2020–FY2025 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/prod-dev-janz
See every metric in the Viatris KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?